Get Premium to unlock powerful stock data

International Biotechnology Trust Plc Buys Horizon Therapeutics PLC, Mirati Therapeutics Inc, Amgen Inc, Sells Regeneron Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc, Biogen Inc

Author's Avatar
insider
Nov 12, 2021
Article's Main Image
Investment company International Biotechnology Trust Plc (Current Portfolio) buys Horizon Therapeutics PLC, Mirati Therapeutics Inc, Amgen Inc, Illumina Inc, Incyte Corp, sells Regeneron Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc, Biogen Inc, United Therapeutics Corp, Acceleron Pharma Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, International Biotechnology Trust Plc. As of 2021Q3, International Biotechnology Trust Plc owns 69 stocks with a total value of $415 million. These are the details of the buys and sells.

For the details of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's stock buys and sells, go to https://www.gurufocus.com/guru/international+biotechnology+trust+plc/current-portfolio/portfolio

These are the top 5 holdings of INTERNATIONAL BIOTECHNOLOGY TRUST PLC
  1. Gilead Sciences Inc (GILD) - 402,784 shares, 6.78% of the total portfolio.
  2. Neurocrine Biosciences Inc (NBIX) - 289,500 shares, 6.69% of the total portfolio. Shares added by 39.86%
  3. Horizon Therapeutics PLC (HZNP) - 237,873 shares, 6.28% of the total portfolio. New Position
  4. Amgen Inc (AMGN) - 118,300 shares, 6.06% of the total portfolio. Shares added by 131.96%
  5. Biohaven Pharmaceutical Holding Co Ltd (BHVN) - 176,400 shares, 5.91% of the total portfolio.
New Purchase: Horizon Therapeutics PLC (HZNP)

International Biotechnology Trust Plc initiated holding in Horizon Therapeutics PLC. The purchase prices were between $91.91 and $110.37, with an estimated average price of $103.79. The stock is now traded at around $108.985000. The impact to a portfolio due to this purchase was 6.28%. The holding were 237,873 shares as of 2021-09-30.

New Purchase: Illumina Inc (ILMN)

International Biotechnology Trust Plc initiated holding in Illumina Inc. The purchase prices were between $405.61 and $524.84, with an estimated average price of $472.7. The stock is now traded at around $383.760000. The impact to a portfolio due to this purchase was 2.64%. The holding were 27,000 shares as of 2021-09-30.

New Purchase: IDEAYA Biosciences Inc (IDYA)

International Biotechnology Trust Plc initiated holding in IDEAYA Biosciences Inc. The purchase prices were between $17.26 and $27.08, with an estimated average price of $23.35. The stock is now traded at around $22.300000. The impact to a portfolio due to this purchase was 0.67%. The holding were 109,000 shares as of 2021-09-30.

New Purchase: Legend Biotech Corp (LEGN)

International Biotechnology Trust Plc initiated holding in Legend Biotech Corp. The purchase prices were between $35.31 and $50.56, with an estimated average price of $41.56. The stock is now traded at around $47.890000. The impact to a portfolio due to this purchase was 0.6%. The holding were 49,500 shares as of 2021-09-30.

New Purchase: Zogenix Inc (ZGNX)

International Biotechnology Trust Plc initiated holding in Zogenix Inc. The purchase prices were between $13.11 and $18.46, with an estimated average price of $15.64. The stock is now traded at around $15.550000. The impact to a portfolio due to this purchase was 0.49%. The holding were 135,000 shares as of 2021-09-30.

New Purchase: Rocket Pharmaceuticals Inc (RCKT)

International Biotechnology Trust Plc initiated holding in Rocket Pharmaceuticals Inc. The purchase prices were between $27.42 and $48.97, with an estimated average price of $36.54. The stock is now traded at around $33.650000. The impact to a portfolio due to this purchase was 0.45%. The holding were 63,000 shares as of 2021-09-30.

Added: Mirati Therapeutics Inc (MRTX)

International Biotechnology Trust Plc added to a holding in Mirati Therapeutics Inc by 482.84%. The purchase prices were between $132.13 and $177.45, with an estimated average price of $161.17. The stock is now traded at around $143.625000. The impact to a portfolio due to this purchase was 3.48%. The holding were 98,500 shares as of 2021-09-30.

Added: Amgen Inc (AMGN)

International Biotechnology Trust Plc added to a holding in Amgen Inc by 131.96%. The purchase prices were between $212.27 and $248.7, with an estimated average price of $230.39. The stock is now traded at around $212.370000. The impact to a portfolio due to this purchase was 3.45%. The holding were 118,300 shares as of 2021-09-30.

Added: Incyte Corp (INCY)

International Biotechnology Trust Plc added to a holding in Incyte Corp by 97.54%. The purchase prices were between $68.67 and $84.02, with an estimated average price of $76.11. The stock is now traded at around $65.470000. The impact to a portfolio due to this purchase was 2.21%. The holding were 270,360 shares as of 2021-09-30.

Added: Travere Therapeutics Inc (TVTX)

International Biotechnology Trust Plc added to a holding in Travere Therapeutics Inc by 1800.00%. The purchase prices were between $12.98 and $25.03, with an estimated average price of $18.37. The stock is now traded at around $29.400000. The impact to a portfolio due to this purchase was 2.1%. The holding were 380,000 shares as of 2021-09-30.

Added: Exelixis Inc (EXEL)

International Biotechnology Trust Plc added to a holding in Exelixis Inc by 382.14%. The purchase prices were between $16.3 and $21.14, with an estimated average price of $18.58. The stock is now traded at around $17.900000. The impact to a portfolio due to this purchase was 1.97%. The holding were 489,534 shares as of 2021-09-30.

Added: Neurocrine Biosciences Inc (NBIX)

International Biotechnology Trust Plc added to a holding in Neurocrine Biosciences Inc by 39.86%. The purchase prices were between $86.18 and $99.03, with an estimated average price of $94.54. The stock is now traded at around $87.705000. The impact to a portfolio due to this purchase was 1.91%. The holding were 289,500 shares as of 2021-09-30.

Sold Out: United Therapeutics Corp (UTHR)

International Biotechnology Trust Plc sold out a holding in United Therapeutics Corp. The sale prices were between $179.86 and $214.88, with an estimated average price of $196.99.

Sold Out: Acceleron Pharma Inc (XLRN)

International Biotechnology Trust Plc sold out a holding in Acceleron Pharma Inc. The sale prices were between $115.25 and $182.78, with an estimated average price of $130.74.

Sold Out: Protagonist Therapeutics Inc (PTGX)

International Biotechnology Trust Plc sold out a holding in Protagonist Therapeutics Inc. The sale prices were between $12.95 and $49.69, with an estimated average price of $42.78.

Sold Out: Halozyme Therapeutics Inc (HALO)

International Biotechnology Trust Plc sold out a holding in Halozyme Therapeutics Inc. The sale prices were between $38.47 and $46.42, with an estimated average price of $41.88.

Sold Out: Sarepta Therapeutics Inc (SRPT)

International Biotechnology Trust Plc sold out a holding in Sarepta Therapeutics Inc. The sale prices were between $65.97 and $92.48, with an estimated average price of $77.05.

Sold Out: Apellis Pharmaceuticals Inc (APLS)

International Biotechnology Trust Plc sold out a holding in Apellis Pharmaceuticals Inc. The sale prices were between $31.4 and $69.84, with an estimated average price of $56.51.

Reduced: Regeneron Pharmaceuticals Inc (REGN)

International Biotechnology Trust Plc reduced to a holding in Regeneron Pharmaceuticals Inc by 79.3%. The sale prices were between $574.03 and $680.96, with an estimated average price of $621.14. The stock is now traded at around $631.230000. The impact to a portfolio due to this sale was -4.62%. International Biotechnology Trust Plc still held 7,700 shares as of 2021-09-30.

Reduced: Alnylam Pharmaceuticals Inc (ALNY)

International Biotechnology Trust Plc reduced to a holding in Alnylam Pharmaceuticals Inc by 49.66%. The sale prices were between $169.75 and $207.73, with an estimated average price of $187.49. The stock is now traded at around $170.665000. The impact to a portfolio due to this sale was -3.52%. International Biotechnology Trust Plc still held 75,000 shares as of 2021-09-30.

Reduced: Biogen Inc (BIIB)

International Biotechnology Trust Plc reduced to a holding in Biogen Inc by 47.42%. The sale prices were between $282.99 and $369.05, with an estimated average price of $328.16. The stock is now traded at around $270.590000. The impact to a portfolio due to this sale was -2.23%. International Biotechnology Trust Plc still held 25,500 shares as of 2021-09-30.

Reduced: Seagen Inc (SGEN)

International Biotechnology Trust Plc reduced to a holding in Seagen Inc by 24.34%. The sale prices were between $142.45 and $169.82, with an estimated average price of $155.61. The stock is now traded at around $177.700000. The impact to a portfolio due to this sale was -1.56%. International Biotechnology Trust Plc still held 109,700 shares as of 2021-09-30.

Reduced: Ionis Pharmaceuticals Inc (IONS)

International Biotechnology Trust Plc reduced to a holding in Ionis Pharmaceuticals Inc by 75.37%. The sale prices were between $33.54 and $40.55, with an estimated average price of $37.74. The stock is now traded at around $32.975000. The impact to a portfolio due to this sale was -1.53%. International Biotechnology Trust Plc still held 44,781 shares as of 2021-09-30.

Reduced: uniQure NV (QURE)

International Biotechnology Trust Plc reduced to a holding in uniQure NV by 42.25%. The sale prices were between $26.01 and $38.22, with an estimated average price of $30.49. The stock is now traded at around $32.065000. The impact to a portfolio due to this sale was -1.15%. International Biotechnology Trust Plc still held 182,194 shares as of 2021-09-30.



Here is the complete portfolio of INTERNATIONAL BIOTECHNOLOGY TRUST PLC. Also check out:

1. INTERNATIONAL BIOTECHNOLOGY TRUST PLC's Undervalued Stocks
2. INTERNATIONAL BIOTECHNOLOGY TRUST PLC's Top Growth Companies, and
3. INTERNATIONAL BIOTECHNOLOGY TRUST PLC's High Yield stocks
4. Stocks that INTERNATIONAL BIOTECHNOLOGY TRUST PLC keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus